Transdermal delivery type hydrogel as well as preparation method and application thereof

A transdermal drug delivery and hydrogel technology, which can be used in pharmaceutical formulations, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc. effect and other issues, to achieve a good hypoglycemic effect, reduce the dosage, and facilitate transdermal absorption.

Inactive Publication Date: 2018-10-16
SUN YAT SEN UNIV
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

With the continuous development of biotechnology, a large number of new drugs are emerging, and traditional drug delivery methods (such as oral or injection) will affect the efficacy of some biosynthetic drugs based on DNA or protein
The pa

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Transdermal delivery type hydrogel as well as preparation method and application thereof
  • Transdermal delivery type hydrogel as well as preparation method and application thereof
  • Transdermal delivery type hydrogel as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0061] Example 1 Preparation of hydrogel (Gel 2: PEG-DA / U-Arg-PEA / Insulin / TD-1)

[0062] 1. The synthesis of arginine unsaturated polyester amide (U-Arg-PEA) includes the following steps:

[0063] (1) Stir fumaryl chloride and p-nitrophenol in acetone containing triethylamine at 0°C for 2 h, and then overnight at room temperature to obtain monomer I, which is recrystallized 3 times in ethyl acetate;

[0064] (2) After mixing arginine and 1,4-butanediol, add to toluene containing p-toluenesulfonic acid monohydrate, heat to 130°C, stir and reflux for 24 hours, then stir the product at 75°C Dissolve in isopropanol, and precipitate 3 times at 4°C to obtain monomer II;

[0065] (3) After adding monomer I and monomer II to dimethyl sulfoxide and mixing uniformly, add triethylamine dropwise until the monomer is completely dissolved; after stirring at 75°C for 48 h, precipitate with ethyl acetate After being dissolved in methanol, it was purified by repeated precipitation with ethyl acetate ...

Example Embodiment

[0076] Example 2 Preparation of hydrogel

[0077] Other conditions are the same as in Example 1, the only difference is: the sum of the mass percentages of the unsaturated polyester amide of arginine and polyethylene glycol diacrylate is 20%, insulin, transdermal peptide, photoinitiator and water The sum of the mass percentages is 80%.

[0078] The hydrogel prepared in this example has a good transdermal absorption effect, can reduce blood glucose concentration efficiently and quickly, and has a complete shape, good elasticity, and good mechanical strength. After testing, its elastic modulus is 0.47 ± 0.15 MPa .

Example Embodiment

[0079] Example 3 Preparation of hydrogel

[0080] Other conditions are the same as in Example 1. The only difference is that the sum of the mass percentages of the unsaturated polyester amide of arginine and polyethylene glycol diacrylate is 10%, insulin, transdermal peptide, photoinitiator and water The sum of the mass percentages is 90%.

[0081] The hydrogel prepared in this example is easy to transdermal absorption, has the effect of significantly promoting the transdermal absorption of insulin, has a good blood sugar lowering effect, and its shape is complete, its properties are good, and its mechanical strength is good. The amount is 0.39 ± 0.20 MPa.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses transdermal delivery type hydrogel as well as a preparation method and application thereof. The hydrogel is prepared from an active component, permeation enhancing peptide, unsaturated polyesteramide of arginine, polyethylene glycol diacrylate, a photoinitiator and water, wherein the sum of the mass percent of the unsaturated polyesteramide of arginine and polyethylene glycol diacrylate is 10 percent to 20 percent; the sum of the mass percent of the active component, the permeation enhancing peptide, the photoinitiator and the water is 80 percent to 90 percent. The hydrogel disclosed by the invention has the advantages of easiness for transdermal absorption, good biocompatibility and no cytotoxicity; a protein-type drug can be loaded very well and insulin is given to patients with diabetes mellitus in a transdermal delivery manner, so that the hydrogel has an efficient blood glucose lowering effect and the utilization dosage of the drug can be greatly reduced; controllable slow release drug administration is also realized in a disease treatment process; the transdermal delivery type hydrogel has high safety and is convenient to use, so that the transdermal delivery type hydrogel is an ideal transdermal patch for clinically treating the diabetes mellitus and has a good application prospect.

Description

technical field [0001] The invention belongs to the technical field of biomedicine. More specifically, it relates to a transdermally administrable hydrogel and its preparation method and application. Background technique [0002] Transdermal administration refers to smearing or applying drugs on the surface of the skin, so that the drugs can pass through the skin (stratum corneum, epidermis and dermis), reach the subcutaneous tissue, and finally reach the lesion through internal circulation to achieve the effect of drug treatment . With the continuous development of biotechnology, a large number of new drugs are constantly emerging, and the traditional drug delivery methods (such as oral or injection) will cause the efficacy of some biosynthetic drugs based on DNA or protein to be affected. The pain of injection administration will bring psychological discomfort to some people, while oral administration has problems such as fluctuations in blood drug concentration, stimula...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/06A61K47/34A61K47/14A61K47/42A61K38/28A61P3/10
CPCA61K9/0014A61K9/06A61K38/28A61K47/14A61K47/34A61K47/42A61P3/10
Inventor 吴钧张少瀚顾志鹏
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap